Results 141 to 150 of about 6,539 (194)

Impact of bromocriptine withdrawal timing on pregnancy outcomes in patients with pituitary prolactin-secreting microadenomas: a real-world retrospective study of 188 pregnancies in China. [PDF]

Front Pharmacol
Lan J, Hong P, Huang W, Xing A, Zhou P, Tan J, Peng X, Fu J.   +7 more
europepmc   +1 more source

Cabergoline Prevents Postpartum Breast Cancer by Enhancing Mammary Gland Involution in Brca1-Mutant Mice and Reduces Risk in Younger Women

García-Sancha N, Corchado-Cobos R, Ghorayeb R, Blanco-Gómez A, Puértolas OC, Alonso-López D, Stoer NC, Mateo F, Espin-Garcia R, Nguyen LTN, Marzo-Castillejo M, Gough C, Milne K, Castillo-Lluva S, Rivas JDL, Pozo J, Orfao A, Palomero L, Pignatelli J, Sacristán-Horcajada E, Valero-Juan L, Patino-Alonso C, Perera D, Venkitaraman A, Mao J, Chang H, Jiménez-Navas A, Pérez-Baena MJ, Salvador N, Mendiburu-Eliçabe M, González P, Caleiras E, Peset I, Cenador MBG, Garcia-Criado FJ, Nelson BH, Botteri E, Pujana MA, Maxwell CA, Pérez-Losada J.   +39 more
europepmc   +1 more source

A new and useful tool for differentiating prolactinomas from non-functioning pituitary adenomas: a pilot study of the cabergoline disconnection test. [PDF]

Einstein (Sao Paulo)
Galliano SA, Stumpf MAM, Queiroz NL, Ferreira EHR, Craveiro FL, Gruetzmacher C, Silva GOD, Cescato VAS, Vellutini EAS, Cunha-Neto MBC, Batista RL, Glezer A.   +11 more
europepmc   +1 more source

When treatment backfires: Dopamine agonist-induced CSF leaks in prolactinomas - Case series and systematic review. [PDF]

Brain Spine
Katsikas A, Gkalonakis I, Georgilaki V, Kyriakopoulos G, Markussis V, Tzanela M, Balakera C, Paleologos TS, Barkas K.   +8 more
europepmc   +1 more source

Real-life data on pasireotide in monotherapy or combined in active Cushing's disease. [PDF]

Front Endocrinol (Lausanne)
Mondin A, Ceccato F, Scaroni C, Denaro L, Manara R, Robertazzo UM, Barbot M.   +6 more
europepmc   +1 more source

Aggressive Macroprolactinoma Refractory to Multiple Lines of Localized and Systemic Therapy. [PDF]

JCEM Case Rep
Konindala N, Paluri R, Darapu H.
europepmc   +1 more source

Long-term primary pharmacotherapy of giant prolactinomas: A comparison of different cabergoline dosages. [PDF]

J Clin Transl Endocrinol
Václav H, Manuela V, Michal K, Adéla K, Jana J, Mikuláš K, Pavel D, David N, Václav M, Martin M, Roman L, Václav H.   +11 more
europepmc   +1 more source

Secondary Loss of Response to Dopamine Receptor Agonists in the Treatment of Macroprolactinoma. [PDF]

Cureus
Alkundi A, Momoh R.
europepmc   +1 more source

Effect of cabergoline on the management of diabetes mellitus: a systematic review and meta-analysis. [PDF]

Cardiovasc Diabetol Endocrinol Rep
Khorasani S, Dara T, Dehghan H, Zabihi M, Saghafi M, Saghafi F.   +5 more
europepmc   +1 more source